Jessica Wasson
Physician Assistant · Stockbridge, GANPI 1205245289
Payments from drug & device makers
Across 492 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AstraZeneca$835
- Novo Nordisk$782
- AbbVie$711
- Pfizer$656
- Kowa Pharmaceuticals America, Inc.$528
- plus $4K from 42 others
What the payments were for
- Food & beverage$8,62199%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,686 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 75 | $117,004 |
| OzempicSemaglutide | 50 | $107,995 |
| FarxigaDapagliflozin Propanediol | 73 | $101,387 |
| TrulicityDulaglutide | 38 | $82,122 |
| JardianceEmpagliflozin | 49 | $71,297 |
| RybelsusSemaglutide | 17 | $39,586 |
| LinzessLinaclotide | 25 | $35,062 |
| EliquisApixaban | 24 | $24,579 |
| MyrbetriqMirabegron | 15 | $19,933 |
| KerendiaFinerenone | 17 | $14,124 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $9,237 |
| XareltoRivaroxaban | 12 | $7,727 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $5,479 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 19 | $3,815 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 81 | $3,408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $1,140 | $199,126113 claims |
| Novo NordiskOzempic, Rybelsus | $782 | $147,58167 claims |
| AstraZenecaFarxiga, Symbicort | $835 | $110,62497 claims |
| Boehringer IngelheimJardiance | $187 | $71,29749 claims |
| AbbVieLinzess, Synthroid | $711 | $36,22139 claims |
| PfizerEliquis | $656 | $24,57924 claims |
| Astellas Pharma US IncMyrbetriq | $228 | $19,93315 claims |
| BayerKerendia | $364 | $14,12417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Stockbridge
- A BrunnerStockbridge$1M
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- Joseph LangshawCalhoun$887K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.